| Drug Type Synthetic peptide vaccine, Therapeutic vaccine | 
| Synonyms FMPV 2, FMPV-2 | 
| Target | 
| Action modulators, stimulants | 
| Mechanism ASTE1 modulators(asteroid homolog 1 modulators), Immunostimulants | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Endometrial Carcinoma | Preclinical | Norway  | 27 Nov 2023 | 





